Overview

Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions

Status:
Completed
Trial end date:
2000-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioavailability of pravastatin sodium 40 mg tablets with that of Pravachol® 40 mg tablets in healthy adult male subjects under fasting conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Teva Pharmaceuticals USA
Treatments:
Pravastatin